Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1275 of 1631 entries
View as:

Naproxen Sodium/ASA Platelet Study

Phase: N/A Priority: Normal
NCT ID: NCT02229461 Org: User:
Start: 02/28/15 End: 05/31/15 Due: 05/31/16

Study to Evaluate How Patients Regard the Benefits and Risks of Low-dose Aspirin for the Prevention of Heart and Blood Vessels Disease and for the Prevention of Cancer of the Colon and Rectum

Phase: N/A Priority: Normal
NCT ID: NCT03603366 Org: User:
Start: 08/14/19 End: 10/14/19 Due: 10/14/20

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Phase: N/A Priority: Normal
NCT ID: NCT05013008 Org: User:
Start: 08/18/21 End: 12/31/21 Due: 12/31/22

An Integrated Analysis of the Effectiveness of Intravitreal (IVT) Aflibercept (Eylea) in Routine Clinical Practice Based on Two Large Observational Studies

Phase: N/A Priority: Normal
NCT ID: NCT03521895 Org: User:
Start: 05/01/18 End: 11/30/18 Due: 11/30/19

A Study to Assess Sorafenib Alone and in Combination With Low-Dose Interferon Following Unsuccessful Treatment With Sunitinib in Patients With Advanced Renal Cell Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT00678288 Org: User:
Start: 04/30/08 End: 06/30/09 Due: 06/30/10

Nexavar Post-marketing Surveillance for Renal Cell Carcinoma in Japan

Phase: N/A Priority: Normal
NCT ID: NCT01411423 Org: User:
Start: 04/18/08 End: 02/28/16 Due: 02/28/17

Phase IV Randomization to On-Going Treatment to Evaluate Sustained Sorafenib

Phase: N/A Priority: Normal
NCT ID: NCT00352859 Org: User:
Start: 08/31/06 End: 11/30/06 Due: 11/30/07

A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03418168 Org: User:
Start: 02/22/18 End: 07/29/19 Due: 07/29/20

A Study to Learn How a Proton Pump Inhibitor Affects the Way Elinzanetant (BAY 3427080) Moves Into, Through and Out of the Body, and How Much of it Gets Absorbed by the Body When Taken as a Single and Small Radioactive Dose in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05061563 Org: User:
Start: 09/30/21 End: 02/23/22 Due: 02/23/23

Research Study for Patients With Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00110344 Org: User:
Start: 11/30/05 End: 06/30/06 Due: 06/30/07

A Phase II Randomized, Double-blind, Placebo-controlled Study of Sorafenib or Placebo in Combination With Transarterial Chemoembolization (TACE) Performed With DC Bead and Doxorubicin for Intermediate Stage Hepatocellular Carcinoma (HCC).

Phase: N/A Priority: Normal
NCT ID: NCT00855218 Org: User:
Start: 03/31/09 End: 02/28/13 Due: 02/28/14

An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States

Phase: N/A Priority: Normal
NCT ID: NCT06029010 Org: User:
Start: 08/31/23 End: 01/27/25 Due: 01/27/26

An Evaluation of a Customized Insole to Provide Relief From Heel Pain Due to Plantar Fasciitis or General Heel Pain When Used in Footwear Over a Period of Four Weeks

Phase: N/A Priority: Normal
NCT ID: NCT03507478 Org: User:
Start: 04/10/18 End: 07/26/18 Due: 07/26/19

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Phase: N/A Priority: Normal
NCT ID: NCT03134573 Org: User:
Start: 09/15/17 End: 05/09/18 Due: 05/09/19

BAY1436032 in Patients With Mutant IDH1(mIDH1) Advanced Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT03127735 Org: User:
Start: 06/14/17 End: 03/15/19 Due: 03/15/20

Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea

Phase: N/A Priority: Normal
NCT ID: NCT02475356 Org: User:
Start: 08/04/15 End: 12/12/19 Due: 12/12/20

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05526157 Org: User:
Start: 10/01/22 End: 09/05/24 Due: 09/05/25

A Trial to Evaluate the Characteristics of Patients Treated for Advanced Renal Cell Carcinoma With Nexavar ®

Phase: N/A Priority: Normal
NCT ID: NCT00771147 Org: User:
Start: 06/30/08 End: 11/30/10 Due: 11/30/11

Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population

Phase: N/A Priority: Normal
NCT ID: NCT02518698 Org: User:
Start: 08/31/15 End: 09/30/17 Due: 09/30/18

Contrast-enhanced MRI in Children 2 Months to <2 Years

Phase: N/A Priority: Normal
NCT ID: NCT00937391 Org: User:
Start: 01/31/10 End: 09/30/10 Due: 09/30/11

Study to Determine the Safety, Maximum Tolerated Dose, Pharmacokinetics of Sorafenib (BAY43-9006)

Phase: N/A Priority: Normal
NCT ID: NCT00941863 Org: User:
Start: 07/31/02 End: 04/30/08 Due: 04/30/09

Study to Assess Bioequivalence of a New Nifurtimox Oral Tablet Formulation

Phase: N/A Priority: Normal
NCT ID: NCT03708133 Org: User:
Start: 12/05/18 End: 06/18/19 Due: 06/18/20

Bioequivalence of Single Dose Phenylephrine Extended Release Tablets and Phenylephrine HCl Immediate Release Tablets Dosed Every Four Hours (P08340)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT01354418 Org: User:
Start: 05/31/11 End: 07/31/11 Due: 07/31/12

COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02253420 Org: User:
Start: 10/08/14 End: 08/13/19 Due: 08/13/20

Efficacy and Safety of Oral Dehydroepiandrosterone as a Concomitant Therapy to Oral Contraceptives in Women Complaining of Reduced Libido

Phase: N/A Priority: Normal
NCT ID: NCT00566384 Org: User:
Start: 11/30/07 End: 04/30/09 Due: 04/30/10